Fahmi Quadir, the young female pharmaceutical analyst whose work exposing problems at Canadian drug company Valeant Pharmaceuticals International earned her a star turn in the Netflix’s “Dirty Money” documentary, has found running a hedge fund quite the challenge, if her first letters to investors are any indication.Quadir launched her short-selling